Comparative efficacy and safety of antipsychotics in the treatment of schizophrenia: a network meta-analysis in a Japanese population

by Kishi T, Ikuta T, Matsunaga S, Matsuda Y, Oya K, Iwata N
Published 2017-05-01

Iminodibenzyl class antipsychotics for schizophrenia: a systematic review and meta-analysis of carpipramine, clocapramine, and mosapramine

by Kishi T, Matsunaga S, Matsuda Y, Iwata N
Published 2014-12-01

Early prediction of blonanserin response in Japanese patients with schizophrenia

by Kishi T, Matsuda Y, Fujita K, Iwata N
Published 2014-09-01

Efficacy and tolerability of topiramate-augmentation therapy for schizophrenia: a systematic review and meta-analysis of randomized controlled trials

by Okuyama Y, Oya K, Matsunaga S, Kishi T, Iwata N
Published 2016-12-01

A randomized trial of aripiprazole vs blonanserin for the treatment of acute schizophrenia and related disorders

by Kishi T, Matsuda Y, Matsunaga S, Mukai T, Moriwaki M, Tabuse H, Fujita K, Iwata N
Published 2016-11-01

Efficacy and tolerability of aripiprazole once monthly for schizophrenia: a systematic review and meta-analysis of randomized controlled trials

by Oya K, Kishi T, Iwata N
Published 2015-09-01

Comparison of the efficacy and safety of 4 and 2 mg/day brexpiprazole for acute schizophrenia: a meta-analysis of double-blind, randomized placebo-controlled trials

by Kishi T, Oya K, Matsui Y, Nomura I, Sakuma K, Okuya M, Matsuda Y, Fujita K, Funahashi T, Yoshimura R, Iwata N
Published 2018-10-01

Aripiprazole for the management of schizophrenia in the Japanese population: a systematic review and meta-analysis of randomized controlled trials

by Kishi T, Matsuda Y, Matsunaga S, Iwata N
Published 2015-02-01

Combination treatment with risperidone long-acting injection and psychoeducational approaches for preventing relapse in schizophrenia

by Zhao Y, Kishi T, Iwata N, Ikeda M
Published 2013-10-01